Guest posting: Dr Nathan Ryder, Clinical Director Sexual Health, Hunter New England Local Health District. Mycoplasma genitalium is an emerging sexually transmitted pathogen. While testing is now widely available in Australia, treatment is becoming increasingly complex. M. genitalium resistance is increasing rapidly and a small but significant proportion of cases are currently untreatable. The benefit of treatment in […]
Guest posting: Dr Nathan Ryder, Clinical Director Sexual Health, Hunter New England Local Health District Managing sexually transmitted infections (STIs) have always presented a number of challenges to primary care physicians. While most bacterial STIs can still be cured with single dose treatments some STIs are becoming increasingly resistant to antibiotics. Therefore it is more […]
Azithromycin is a macrolide antibiotic with broad-spectrum bacteriostatic activity against many Gram-positive and Gram-negative bacteria. It also has activity against Mycoplasma pneumoniae, Treponema pallidum, Chlamydia sp. and Mycobacterium avium complex. In addition azithromycin has immunomodulating effects and is used in chronic respiratory inflammatory diseases, including cystic fibrosis, as an anti-inflammatory.